Bevacizumab and Temozolomide Following Radiation and Chemotherapy for Newly Diagnosed Glioblastoma Multiforme
Clinical trial NCT00590681 · COMPLETED
Trial details
- NCT number
- NCT00590681
- Sponsor
- University of Chicago
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-02-01
- Primary completion
- 2014-09-01
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.